Transchem

Transchem EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Transchem (500422.BO) as of Oct 21, 2026 is -121.98. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 4.21 — a change of -2,999.11% (lower).

EV/FCF

-121.98

YoY

-2,999.11%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Transchem is 2026 -121.98 . EV/FCF (Enterprise Value to Free Cash Flow) of Transchem was 2025 4.21 . It decreases by -2,999.11% lower compared to the previous year.

The Transchem EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2019
17.14 INR
Jan 1, 2020
-278.96 INR
Jan 1, 2021
-6.50 INR
Jan 1, 2022
7.26 INR
Jan 1, 2023
130.04 INR
Jan 1, 2024
-4.89 INR
Jan 1, 2025
4.21 INR
Jan 1, 2026
-121.98 INR
The Transchem EV/FCF history
YEAREV/FCFYoY
-121.98-2,999.11%
4.21-186.13%
-4.89-103.76%
130.04+1,691.85%
7.26-211.67%
-6.50-97.67%
-278.96-1,727.41%
17.14-283.52%
-9.34-103.11%
300.29+87.97%
159.76-16.10%
190.42-43.30%
335.85—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Transchem Stock analysis

What does Transchem do? Transchem Ltd is a pharmaceutical company based in Thane, India, operating within the Health Care sector. The company has been publicly traded since its IPO on January 27, 1993, with a ticker symbol of 500422.BO and ISIN code INE019B01010. Its headquarters are located in Thane, Maharashtra. Transchem Ltd is engaged in the production and processing of pharmaceutical products, though specific product details are not provided. The company's website is https://www.transchem.net/. While the source description mentions the company's involvement in mushroom production, this appears to be an unverified or incorrect detail, as the company is classified under the Pharmaceuticals industry. The source also states that the company temporarily invests funds in short-term treasury operations while seeking new business opportunities, but this information should be treated with caution as it is not confirmed by official company sources. The company's primary focus remains on pharmaceutical manufacturing and processing within the Indian market. No additional details about its founding year, key personnel, acquisitions, or financial figures are provided in the available information. Transchem Ltd operates as a publicly listed entity on the Bombay Stock Exchange, though specific market capitalization or trading volume data is not included in the given facts. The company's activities are centered around pharmaceutical production, with no indication of other significant business lines beyond those related to the Health Care sector. Transchem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Transchem stock

EV/FCF (Enterprise Value to Free Cash Flow) of Transchem is -121.98 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of Transchem changed from 4.21 to -121.98, representing a -2,999.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Transchem since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Transchem with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Transchem

All Key Metrics — Transchem